Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jonathan Zheng Li, M.D.

Co-Author

This page shows the publications co-authored by Jonathan Li and Manish Choudhary.
Connection Strength

2.587
  1. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Sequence Characteristics of Coronavirus Disease 2019 (COVID-19) Persistence and Reinfection. Clin Infect Dis. 2022 01 29; 74(2):237-245.
    View in: PubMed
    Score: 0.984
  2. Duration of viral shedding and culture positivity with postvaccination SARS-CoV-2 delta variant infections. JCI Insight. 2022 01 25; 7(2).
    View in: PubMed
    Score: 0.246
  3. Emergence of SARS-CoV-2 Resistance with Monoclonal Antibody Therapy. medRxiv. 2021 Sep 15.
    View in: PubMed
    Score: 0.240
  4. Impact of pre-existing drug resistance on risk of virological failure in South Africa. J Antimicrob Chemother. 2021 05 12; 76(6):1558-1563.
    View in: PubMed
    Score: 0.234
  5. Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host. N Engl J Med. 2020 12 03; 383(23):2291-2293.
    View in: PubMed
    Score: 0.226
  6. Determining the Incidence of Asymptomatic SARS-CoV-2 Among Early Recipients of COVID-19 Vaccines (DISCOVER-COVID-19): A Prospective Cohort Study of Healthcare Workers Before, During and After Vaccination. Clin Infect Dis. 2022 Apr 09; 74(7):1275-1278.
    View in: PubMed
    Score: 0.062
  7. Fecal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) RNA Is Associated With Decreased Coronavirus Disease 2019 (COVID-19) Survival. Clin Infect Dis. 2022 03 23; 74(6):1081-1084.
    View in: PubMed
    Score: 0.062
  8. Vaccine Breakthrough Infection with the SARS-CoV-2 Delta or Omicron (BA.1) Variant Leads to Distinct Profiles of Neutralizing Antibody Responses. medRxiv. 2022 Mar 03.
    View in: PubMed
    Score: 0.062
  9. Duration of viable virus shedding in SARS-CoV-2 omicron variant infection. medRxiv. 2022 Mar 02.
    View in: PubMed
    Score: 0.062
  10. Detection of the Omicron Variant Virus With the Abbott BinaxNow SARS-CoV-2 Rapid Antigen Assay. Open Forum Infect Dis. 2022 Mar; 9(3):ofac022.
    View in: PubMed
    Score: 0.061
  11. Virologic Features of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Children. J Infect Dis. 2021 12 01; 224(11):1821-1829.
    View in: PubMed
    Score: 0.061
  12. Genome-wide association analysis of COVID-19 mortality risk in SARS-CoV-2 genomes identifies mutation in the SARS-CoV-2 spike protein that colocalizes with P.1 of the Brazilian strain. Genet Epidemiol. 2021 10; 45(7):685-693.
    View in: PubMed
    Score: 0.059
  13. SARS-CoV-2 evolution in an immunocompromised host reveals shared neutralization escape mechanisms. Cell. 2021 05 13; 184(10):2605-2617.e18.
    View in: PubMed
    Score: 0.058
  14. Prospective mapping of viral mutations that escape antibodies used to treat COVID-19. Science. 2021 02 19; 371(6531):850-854.
    View in: PubMed
    Score: 0.057
  15. Prospective mapping of viral mutations that escape antibodies used to treat COVID-19. bioRxiv. 2020 Dec 01.
    View in: PubMed
    Score: 0.057
  16. SARS-CoV-2 viral load is associated with increased disease severity and mortality. Nat Commun. 2020 10 30; 11(1):5493.
    View in: PubMed
    Score: 0.056
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.